13.43 USD
▲+0.34+3.87%
盘后 12.95 +0.12%
2026-08-03
市值
$365.09M
市盈率
—
EPS
-1.64
股息率
—
52 周区间
8.50 – 17.19
成交量
160.51K
Beta
—
目标价
18.60
52W 低 8.5052W 高 17.19
价格走势
公司简介
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.